» Authors » Ponnusamy Kalaiarasan

Ponnusamy Kalaiarasan

Explore the profile of Ponnusamy Kalaiarasan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 19
Citations 215
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Naseem A, Bhat Z, Kalaiarasan P, Kumar B, Hafeez Z, Tiwari R, et al.
J Cell Biochem . 2019 May; 120(9):15851-15866. PMID: 31074114
Genetic and epigenetic anomalies accountable for genetic dysregulation are the most common aberrations that determine the underlying heterogeneity of the tumor cells. Currently, phosphatase and tensin homolog (PTEN) incongruity has...
2.
Saini S, Kalaiarasan P, Singh R, Manvati S, Bamezai R
Mitochondrion . 2018 Apr; 43:30-36. PMID: 29674166
The present study on the basis of a detailed bioinformatics analysis proposed a potential role of a miRNA, hsa-miR-19b-2-5p, in regulating the mitochondrial biogenesis. The miRNA has shown to be...
3.
Kashif M, Tabrez S, Husein A, Arish M, Kalaiarasan P, Manna P, et al.
J Cell Biochem . 2017 Oct; 119(3):2653-2665. PMID: 29058760
Leishmania, a protozoan parasite that causes leishmaniasis, affects 1-2 million people every year worldwide. Leishmaniasis is a vector born disease and characterized by a diverse group of clinical syndromes. Current...
4.
Naseem A, Bhat Z, Kalaiarasan P, Kumar B, Gandhi G, Rizvi M
Tumour Biol . 2017 Jun; 39(6):1010428317703635. PMID: 28631565
The recent investigation on PARK-2, a putative tumor suppressor gene, has found that it has been altered in multiple human malignancies. However, the clinical impact of PARK-2 alteration in uterine...
5.
Singh R, Saini S, Verma D, Kalaiarasan P, Bamezai R
Mitochondrion . 2017 May; 35:35-43. PMID: 28502718
We have previously observed concomitant events of mutations in mitochondrial and nuclear genes, along with elevated reactive oxygen species (ROS) and differential methylation within the promoters of nuclear genes in...
6.
Ali S, Nafis S, Kalaiarasan P, Rai E, Sharma S, Bamezai R
Rev Diabet Stud . 2016 Aug; 13(1):17-34. PMID: 27563694
Type 2 diabetes (T2D) is a chronic metabolic disease which shows an exponential increase in all parts of the world. However, the disease is controllable by early detection and modified...
7.
Chaturvedi S, Alam P, Khan J, Siddiqui M, Kalaiarasan P, Subbarao N, et al.
Int J Biol Macromol . 2015 Jun; 80:375-84. PMID: 26111912
In this work, we investigated the inhibitory ability of taurine on the aggregation of Human serum albumin (HSA) and also examined how it controls the kinetic parameters of the aggregation...
8.
Kalaiarasan P, Kumar B, Chopra R, Gupta V, Subbarao N, Bamezai R
PLoS One . 2015 Mar; 10(3):e0120469. PMID: 25768091
Role of, 29-non-synonymous, 15-intronic, 3-close to UTR, single nucleotide polymorphisms (SNPs) and 2 mutations of Human Pyruvate Kinase (PK) M2 were investigated by in-silico and in-vitro functional studies. Prediction of...
9.
Baig M, Sudhakar D, Kalaiarasan P, Subbarao N, Wadhawa G, Lohani M, et al.
PLoS One . 2014 Dec; 9(12):e112456. PMID: 25479359
Bacterial resistance is a serious threat to human health. The production of β-lactamase, which inactivates β-lactams is most common cause of resistance to the β-lactam antibiotics. The Class A enzymes...
10.
Singh R, Srivastava A, Kalaiarasan P, Manvati S, Chopra R, Bamezai R
Sci Rep . 2014 Oct; 4:6571. PMID: 25300428
mtDNA non-synonymous germ line variation (G10398A; p.A114T) has remained equivocal with least mechanistic understanding in showing an association with cancer. This has necessitated showing in-vitro how an over-expression within mitochondria...